-- Preview Email Newsletter
| U.S. Congressional Tipoffs Involving Maine Newsletter for 2022-04-12 ( 4 items ) |
|
Nearly $2.2 Billion for Diabetes Research Signed Into Law Following Sen. Collins' Advocacy (10)
WASHINGTON, April 12 -- Sen. Susan M. Collins, R-Maine, issued the following news release on April 11, 2022:
U.S. Senator Susan Collins, a senior member of the Appropriations Committee and the founder and co-chair of the Senate Diabetes Caucus, announced that the government funding bill that was recently signed into law included $2.2 billion to support diabetes research, an increase of $71.95 million.
"The groundbreaking discoveries made possible by advancements in diabetes research are alread more PR
Sens. Collins, King Applaud Inclusion of Two Maine Universities in $6 Million Biotechnology Research Project (10)
WASHINGTON, April 12 -- Sen. Susan M. Collins, R-Maine, issued the following news release on April 11, 2022:
U.S. Senators Susan Collins and Angus King today applauded the inclusion of the University of Maine (UMaine) and the University of New England (UNE) in a $6 million program to advance research in quality control of biomanufacturing and biotechnology. The program is led by the National Science Foundation and funded by the U.S. Department of Energy's Established Program to Stimulate Compet more PR
Sens. Collins, King Applaud Inclusion of Two Maine Universities in $6 Million Biotechnology Research Project (10)
WASHINGTON, April 12 -- Sen. Angus S. King Jr., I-Maine, issued the following news release on April 11, 2022:
U.S. Senators Susan Collins and Angus King today applauded the inclusion of the University of Maine (UMaine) and the University of New England (UNE) in a $6 million program to advance research in quality control of biomanufacturing and biotechnology. The program is led by the National Science Foundation and funded by the U.S. Department of Energy's Established Program to Stimulate Compe more PR
Sens. Collins, Shaheen, Reps. DeGette & Reed Unveil Bipartisan Policy Priorities to Lower Insulin Costs, Invite Lawmakers and Stakeholders to Share Input on Final Legislation (10)
WASHINGTON, April 12 -- Sen. Susan M. Collins, R-Maine, issued the following news release on April 11, 2022:
U.S. Senators Susan Collins (R-ME) and Jeanne Shaheen (D-NH) - Co-Chairs of the Senate Diabetes Caucus - unveiled new bipartisan policy priorities today with House Diabetes Caucus Co-Chairs Diana DeGette (CO-01) and Tom Reed (NY-23) to lower skyrocketing insulin costs. Senators Collins and Shaheen also invited their Senate colleagues to provide input as the members finalize their legisla more PR
|